2065 studies found for:    "Endocrine Gland Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Conditions: Acromegaly;   Gigantism;   Familial Isolated Pituitary Adenoma;   FIPA;   Pituitary Adenoma Predisposition;   PAP
Intervention:
22 Completed Evaluation of Blood Vessel Formation in Endocrine Tumors
Condition: Lesions
Intervention:
23 Not yet recruiting Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor
Conditions: Pancreatic Tumor;   Endocrine Tumor;   Neoplasms, Cystic, Mucinous, and Serous
Intervention: Procedure: Radiofrequency Ablation under EUS
24 Recruiting Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Conditions: Sarcoma;   Endocrine Tumors;   Neuroblastoma;   Retinoblastoma;   Renal Cancer
Intervention:
25 Terminated Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
Conditions: Colon Tumors;   Rectum Tumors;   Appendix Tumors;   Peritoneum Tumors;   Endocrine Tumors
Intervention: Drug: Oxaliplatin and irinotecan
26 Completed Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
Conditions: Carcinoma;   Carcinoma, Renal Cell;   Neuroendocrine Tumors;   Carcinoid Tumor;   Pancreatic Islet Cell Tumors
Intervention: Other: Blood sampling by vena punction.
27 Recruiting Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Hepatic Metastases;   Metastases
Interventions: Drug: Everolimus;   Device: embolization;   Drug: Doxorubicin
28 Recruiting PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation
Condition: Neuroendocrine Tumors
Intervention: Procedure: 68Ga-DOTATOC PET-CT Imaging
29 Terminated
Has Results
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
Condition: Pancreatic Cancer
Interventions: Drug: Avastin;   Drug: Fluorouracil;   Drug: Doxorubicin;   Drug: Streptozocin;   Drug: Dexamethasone;   Drug: Ondansetron
30 Recruiting RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Conditions: Carcinoma;   Neuroendocrine;   Non Functioning Neuroendocrine Tumors/NET;   Non Syndromic Neuroendocrine Tumors/NET;   Carcinoids;   Non Functioning
Intervention: Drug: Everolimus
31 Recruiting Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs
Condition: Well Differentiated Pancreatic Endocrine Tumor
Intervention: Drug: Everolimus plus Octreotide LAR plus Metformin
32 Completed
Has Results
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
Condition: Neoplasms
Interventions: Drug: bevacizumab [Avastin];   Drug: 5 FU;   Drug: Streptozotocin;   Drug: Xeloda
33 Completed Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
Conditions: Muscle Rigidity;   Spasm;   Stiff Man Syndrome
Intervention: Drug: IVIg
34 Completed Vancomycin Associated Red Man Syndrome (RMS)
Condition: Red Man Syndrome
Intervention:
35 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
36 Recruiting ImmunoTEP for Patients With Medullary Thyroid Carcinoma.
Condition: Medullary Thyroid Carcinoma
Intervention: Drug: • TF2 and 68 Ga-IMP-288
37 Unknown  Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
Conditions: Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Neoplastic Syndrome
Interventions: Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium
38 Completed Assess Cancer in Ovarian Tumors With Biomarkers.
Condition: Ovarian Tumor
Intervention: Procedure: Blood Draw
39 Suspended MLN0128 and Ziv-Aflibercept in Treating Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Adult Solid Neoplasm;   Gastrin-Producing Neuroendocrine Tumor;   Pancreatic Glucagonoma;   Pancreatic Insulinoma;   Pancreatic Polypeptide Tumor;   Recurrent Ovarian Carcinoma;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Pancreatic Neuroendocrine Carcinoma;   Somatostatin-Producing Neuroendocrine Tumor;   Stage IIIA Ovarian Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIB Ovarian Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIC Ovarian Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IV Ovarian Cancer;   Stage IV Ovarian Germ Cell Tumor
Interventions: Drug: TORC1/2 Inhibitor INK128;   Biological: Ziv-Aflibercept;   Other: Laboratory Biomarker Analysis
40 Completed Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer
Intervention: Biological: recombinant interleukin-12

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years